NCT05304208View on ClinicalTrials.gov

dENdritic Cell Therapy Combined With SURgEry in Mesothelioma

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Mesotheliomas Pleural
Interventions
BIOLOGICAL

Mesopher

autologous monocyte-derived DCs loaded with PheraLys (tumor cell lysate)

Trial Locations (1)

3015 GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER